Related references
Note: Only part of the references are listed.Determinants of generic vs. brand drug choice: Evidence from population-wide Danish data
Niels Skipper et al.
SOCIAL SCIENCE & MEDICINE (2015)
THE RESPONSE OF DRUG EXPENDITURE TO NONLINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D
Liran Einav et al.
QUARTERLY JOURNAL OF ECONOMICS (2015)
Physician Agency and Adoption of Generic Pharmaceuticals
Toshiaki Iizuka
AMERICAN ECONOMIC REVIEW (2012)
Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan
Ya-Ming Liu et al.
JOURNAL OF HEALTH ECONOMICS (2009)
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis
Aaron S. Kesselheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Health as human capital: synthesis and extensions
Gary S. Becker
OXFORD ECONOMIC PAPERS-NEW SERIES (2007)
Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India
Shubham Chaudhuri et al.
AMERICAN ECONOMIC REVIEW (2006)
Inequalities in access to medical care by income in developed countries
E van Doorslaer et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Estimating regression models in which the dependent variable is based on estimates
JB Lewis et al.
POLITICAL ANALYSIS (2005)
Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures
TE Getzen
JOURNAL OF HEALTH ECONOMICS (2000)
Share Paper
